These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Suicidality in pediatric patients treated with antidepressant drugs. Hammad TA, Laughren T, Racoosin J. Arch Gen Psychiatry; 2006 Mar; 63(3):332-9. PubMed ID: 16520440 [Abstract] [Full Text] [Related]
4. Selective serotonin reuptake inhibitors (SSRIs) for depressive disorders in children and adolescents. Hetrick S, Merry S, McKenzie J, Sindahl P, Proctor M. Cochrane Database Syst Rev; 2007 Jul 18; (3):CD004851. PubMed ID: 17636776 [Abstract] [Full Text] [Related]
5. Continuation treatment with antidepressants in child and adolescent major depression. Ryan ND. Am J Psychiatry; 2008 Apr 18; 165(4):411-2. PubMed ID: 18381908 [No Abstract] [Full Text] [Related]
6. Is there evidence for negative effects of antidepressants on suicidality in depressive patients? A systematic review. Möller HJ. Eur Arch Psychiatry Clin Neurosci; 2006 Dec 18; 256(8):476-96. PubMed ID: 17143567 [Abstract] [Full Text] [Related]
7. How have the SSRI antidepressants affected suicide risk? Hall WD. Lancet; 2006 Jun 17; 367(9527):1959-62. PubMed ID: 16782468 [No Abstract] [Full Text] [Related]
8. Use of selective serotonin reuptake inhibitors in children and adolescents. Wong IC, Besag FM, Santosh PJ, Murray ML. Drug Saf; 2004 Jun 17; 27(13):991-1000. PubMed ID: 15471506 [Abstract] [Full Text] [Related]
9. [Selective serotonin reuptake inhibitors in major depressive disorder in children and adolescents (ratio of benefits/risks)]. Hjalmarsson L, Corcos M, Jeammet P. Encephale; 2005 Jun 17; 31(3):309-16. PubMed ID: 16142045 [Abstract] [Full Text] [Related]
10. Pharmacological treatment of children and adolescents with depression. Vitiello B, Ordóñez AE. Expert Opin Pharmacother; 2016 Dec 17; 17(17):2273-2279. PubMed ID: 27690663 [Abstract] [Full Text] [Related]
11. Lines of evidence on the risks of suicide with selective serotonin reuptake inhibitors. Healy D. Psychother Psychosom; 2003 Dec 17; 72(2):71-9. PubMed ID: 12601224 [Abstract] [Full Text] [Related]
12. Antidepressants and the risk of suicidal behaviors. Jick H, Kaye JA, Jick SS. JAMA; 2004 Jul 21; 292(3):338-43. PubMed ID: 15265848 [Abstract] [Full Text] [Related]
13. Are selective serotonin reuptake inhibitors a risk factor for adolescent suicide? Healy D. Can J Psychiatry; 2009 Feb 21; 54(2):69-71; discussion 76-7. PubMed ID: 19254434 [No Abstract] [Full Text] [Related]
15. Evaluating suicide-related adverse events in clinical trials of fluoxetine treatment in adults for indications other than major depressive disorder. Tauscher-Wisniewski S, Disch D, Plewes J, Ball S, Beasley CM. Psychol Med; 2007 Nov 21; 37(11):1585-93. PubMed ID: 17640442 [Abstract] [Full Text] [Related]
18. How have the selective serotonin reuptake inhibitor antidepressants affected suicide mortality? Hall WD, Lucke J. Aust N Z J Psychiatry; 2006 Nov 21; 40(11-12):941-50. PubMed ID: 17054562 [Abstract] [Full Text] [Related]
19. WITHDRAWN: Treatment discontinuation with selective serotonin reuptake inhibitors (SSRIs) versus tricyclic antidepressants (TCAs). Barbui C, Hotopf M, Freemantle N, Boynton J, Churchill R, Eccles MP, Geddes JR, Hardy R, Lewis G, Mason JM. Cochrane Database Syst Rev; 2007 Jul 18; (3):CD002791. PubMed ID: 17636706 [Abstract] [Full Text] [Related]